» Articles » PMID: 28104984

Role of Mast Cell-miR-490-5p in Irritable Bowel Syndrome

Overview
Specialty Gastroenterology
Date 2017 Jan 21
PMID 28104984
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To determine the functional role of miR-490-5p in mast cell proliferation and apoptosis, and in the mast cell tryptase/PAR-2 signal pathway.

Methods: The 3 generation of lentivirus vector systems containing enhanced green fluorescent protein (EGFP) (Ruisai Inc., Shanghai, China), which acts as a reporter gene was used to construct the mmu-miR-490-5p lentivirus expression vector pEGFP-antagomiR-490-5p, and the lentivirus vector pEGFP-negative was used as a negative control. The stably transfected mast cell line p815 was then constructed. GFP positive cells were successfully transfected cells. We determined the expression of miR-490-5p in p815 mast cells before and after transfection using quantitative real-time PCR (qRT-PCR). In addition, after transduction with the lentivirus vectors, the role of miR-490-5p in mast cell proliferation and apoptosis was investigated using the CCK-8 assay and flow cytometry, respectively. The mRNA levels of tryptase and PAR-2 were detected by qRT-PCR and the protein levels were detected by Western blot.

Results: The inhibition of miR-490-5p expression promoted apoptosis and inhibited proliferation of p815 mast cells. The mRNA levels of tryptase and PAR-2 were significantly increased after transfection compared with the control group, tryptase ( = 0.721, normal null; = 0.001, siRNA normal; = 0.002, siRNA null) and PAR-2 ( = 0.027, siRNA null; = 0.353, normal null; = 0.105, siRNA normal). The protein levels of tryptase and PAR2 were slightly higher in the siRNA group than those in the control group, but the difference was not statistically significant ( > 0.05).

Conclusion: miR-490-5p plays a vital role in the pathogenesis of irritable bowel syndrome by affecting mast cell proliferation and apoptosis; with down-regulation of miR-490-5p, the mRNA level of mast cell tryptase and PAR-2 increased, and the protein level increased, but the difference was not statistically significant.

Citing Articles

Mast cell-mediated microRNA functioning in immune regulation and disease pathophysiology.

Deng Q, Yao X, Fang S, Sun Y, Liu L, Li C Clin Exp Med. 2025; 25(1):38.

PMID: 39812911 PMC: 11735496. DOI: 10.1007/s10238-024-01554-2.


New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics.

Dothel G, Barbaro M, Di Vito A, Ravegnini G, Gorini F, Monesmith S J Gastroenterol. 2023; 58(7):605-621.

PMID: 37160449 PMC: 10307698. DOI: 10.1007/s00535-023-01997-6.


Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review.

Bravo-Vazquez L, Medina-Rios I, Marquez-Gallardo L, Reyes-Munoz J, Serrano-Cano F, Pathak S Dig Dis Sci. 2022; 68(1):38-53.

PMID: 35507132 PMC: 9066399. DOI: 10.1007/s10620-022-07516-6.


Role of microRNAs in Disorders of Gut-Brain Interactions: Clinical Insights and Therapeutic Alternatives.

Singh R, Zogg H, Ro S J Pers Med. 2021; 11(10).

PMID: 34683162 PMC: 8541612. DOI: 10.3390/jpm11101021.


Micro-organic basis of functional gastrointestinal (GI) disorders: Role of microRNAs in GI pacemaking cells.

Singh R, Wei L, Ghoshal U Indian J Gastroenterol. 2021; 40(2):102-110.

PMID: 33738768 DOI: 10.1007/s12664-021-01159-7.


References
1.
Zhang Z, Duan Z, Wang L, Yang D, Zhao G, Zhang L . The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies. BMC Gastroenterol. 2014; 14:23. PMC: 3926682. DOI: 10.1186/1471-230X-14-23. View

2.
Cenac N, Andrews C, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P . Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest. 2007; 117(3):636-47. PMC: 1794118. DOI: 10.1172/JCI29255. View

3.
Mansour M, Sabbah N, Mansour S, Ibrahim A . MicroRNA-199b expression level and coliform count in irritable bowel syndrome. IUBMB Life. 2016; 68(5):335-42. DOI: 10.1002/iub.1495. View

4.
Bashashati M, Rezaei N, Bashashati H, Shafieyoun A, Daryani N, Sharkey K . Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2012; 24(12):1102-e566. DOI: 10.1111/j.1365-2982.2012.01990.x. View

5.
Mayer E, Bradesi S, Chang L, Spiegel B, Bueller J, Naliboff B . Functional GI disorders: from animal models to drug development. Gut. 2007; 57(3):384-404. PMC: 4130737. DOI: 10.1136/gut.2006.101675. View